TD Waterhouse Canada’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
2,051
-600
| -23% | -$76.5K | ﹤0.01% | 774 |
|
|
2025
Q1 | $329K | Sell |
2,651
-3,164
| -54% | -$393K | ﹤0.01% | 718 |
|
|
2024
Q4 | $769K | Sell |
5,815
-6,553
| -53% | -$866K | 0.01% | 552 |
|
|
2024
Q3 | $1.79M | Buy |
12,368
+486
| +4% | +$70.3K | 0.01% | 408 |
|
|
2024
Q2 | $1.63M | Buy |
11,882
+7,244
| +156% | +$993K | 0.01% | 407 |
|
|
2024
Q1 | $650K | Buy |
4,638
+2,384
| +106% | +$334K | ﹤0.01% | 568 |
|
|
2023
Q4 | $338K | Sell |
2,254
-707
| -24% | -$106K | ﹤0.01% | 598 |
|
|
2023
Q3 | $387K | Buy |
2,961
+830
| +39% | +$108K | ﹤0.01% | 554 |
|
|
2023
Q2 | $279K | Sell |
2,131
-119
| -5% | -$15.6K | ﹤0.01% | 618 |
|
|
2023
Q1 | $305K | Sell |
2,250
-658
| -23% | -$89.1K | ﹤0.01% | 598 |
|
|
2022
Q4 | $391K | Buy |
2,908
+463
| +19% | +$62.3K | ﹤0.01% | 560 |
|
|
2022
Q3 | $303K | Sell |
2,445
-12,391
| -84% | -$1.53M | ﹤0.01% | 594 |
|
|
2022
Q2 | $2.09M | Buy |
14,836
+13,124
| +767% | +$1.85M | 0.02% | 311 |
|
|
2022
Q1 | $245K | Buy |
1,712
+36
| +2% | +$5.15K | ﹤0.01% | 689 |
|
|
2021
Q4 | $267K | Buy |
+1,676
| New | +$267K | ﹤0.01% | 710 |
|